Hepatocellular carcinoma in Japanese patients with nonalcoholic fatty liver disease, alcoholic liver disease, and chronic liver disease of unknown etiology: report of the nationwide survey
- 668 Downloads
To clarify the etiology of hepatocellular carcinoma (HCC) in Japanese patients with non-viral liver disease, we performed a nationwide survey. The influence of obesity, lifestyle-related diseases, and alcohol consumption was focused on.
A nationwide survey of 14,530 HCC patients was conducted in 2009. Clinical features were studied for HCC patients with nonalcoholic fatty liver disease (NAFLD-HCC; n = 292), alcoholic liver disease (ALC-HCC; n = 991), and chronic liver disease of unknown etiology (unknown HCC; n = 614). The unknown HCC was divided into two subgroups, a no alcohol intake group and a modest alcohol intake group.
ALC-HCC accounted for 7.2% of all HCC, followed by unknown HCC (5.1%) and NAFLD-HCC (2.0%). The characteristics of these three groups were clearly different (median age was 72 years for NAFLD-HCC, 68 years for ALC-HCC, and 73 years for unknown HCC, p < 0.01; female gender was 38, 4, and 37%, respectively, p < 0.01). Obesity and lifestyle-related diseases were significantly more frequent in NAFLD-HCC than in ALC-HCC and unknown HCC. The no alcohol intake subgroup of unknown HCC showed female predominance (58%) and was older, without a high prevalence of obesity and lifestyle-related diseases. In contrast, the modest alcohol intake subgroup showed the same trends regarding gender, body mass index, prevalence of lifestyle-related diseases, and liver function as the ALC-HCC group.
The clinical features of ALC-HCC, NAFLD-HCC, and unknown HCC were clearly different. Modest intake of alcohol might have a more significant role in hepatic carcinogenesis than is presently thought.
KeywordsHepatocellular carcinoma Alcoholic liver disease Nonalcoholic fatty liver disease Questionnaire survey
- 1.World Health Organization. Mortality database. http://www.who.int/whosis/en (Accessed February 2010).
- 4.Health and Welfare Statistics Association. J Health Welf Stat. 2009;56(9):39–89.Google Scholar
- 5.Ikai I, Kudo M, Arii S, Omata M, Kojiro M, Sakamoto M, et al. Report of the 18th follow-up survey of primary liver cancer. Hepatol Res. 2010;40:1043–59.Google Scholar
- 13.Brunt EM. Nonalcoholic steatohepatitis. Semin Liver Dis. 2004;2:3–20.Google Scholar
- 14.Matsuzawa Y, Inoue S, Ikeda Y, Sakata T, Saitou Y, Satou Y et al. New diagnosis and classification of obesity. J Jpn Soc Study Obes. 2000:6:18–28 (in Japanese).Google Scholar
- 15.Examination Committee of Criteria for Metabolic Syndrome in Japan. Definition and diagnosis for metabolic syndrome. J Jpn Soc Intern Med. 2005;94:784–809 (in Japanese).Google Scholar
- 20.Fattovich G, Stroffolini T, Zagni I, Donato F. Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology. 2004;127(5 Suppl 1):S35–50.Google Scholar
- 21.Davis GL, Dempster J, Meler JD, Orr DW, Walberg MW, Brown B, et al. Hepatocellular carcinoma: management of an increasingly common problem. Proc (Bayl Univ Med Cent). 2008;21:266–80.Google Scholar
- 27.Nakagawa H, Maeda S, Yoshida H, Tateishi R, Masuzaki R, Ohki T et al. Serum IL-6 levels and the risk for hepatocarcinogenesis in chronic hepatitis C patients: an analysis based on gender differences. Int J Cancer. 2009;125:2264–9.Google Scholar
- 32.Tokushige K, Hashimoto E, Tobari M, Yatsuji S, Takakura M, Taniai M et al. The effect of previous HBV infection on hepatocellular carcinoma with alcoholic liver disease. Nihon Arukoru Yakubutsu Igakkai Zasshi. 2006;41:120–7 (in Japanese).Google Scholar